S.C. ROPHARMA S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.195 RON | +4.84% |
|
+2.63% | -2.50% |
| 2023 | S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| Sales 2021 | 888M 192M 263M | Sales 2022 | 1B 217M 296M | Capitalization | 95.61M 20.67M 28.26M |
|---|---|---|---|---|---|
| Net income 2021 | 10M 2.16M 2.96M | Net income 2022 | 9M 1.95M 2.66M | EV / Sales 2021 | 0.26 x |
| Net Debt 2021 | 126M 27.28M 37.28M | Net Debt 2022 | 133M 28.73M 39.27M | EV / Sales 2022 | 0.23 x |
| P/E ratio 2021 * |
-
| P/E ratio 2022 |
10.4
x | Employees | 880 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 36.9% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.84% | ||
| 1 week | +2.63% | ||
| 1 month | +0.52% | ||
| 3 months | -7.14% | ||
| 6 months | +5.41% | ||
| Current year | -2.50% |
1 week
0.19
0.20
1 month
0.170.20
Current year
0.170.23
1 year
0.170.23
3 years
0.160.24
5 years
0.160.37
10 years
0.160.40
| Managers | Title | Age | Since |
|---|---|---|---|
Mihai Miron
CEO | Chief Executive Officer | 63 | - |
| Director of Finance/CFO | 51 | 06-12-31 | |
Danut-Marian Ene
BRD | Director/Board Member | 55 | 06-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mihai Miron
CEO | Chief Executive Officer | 63 | - |
| Director of Finance/CFO | 51 | 06-12-31 | |
Florentina Miron
BRD | Director/Board Member | 68 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 0.195 | +4.84% | 1,170 |
| 24-04-25 | 0.186 | -3.63% | 200,000 |
| 24-04-24 | 0.193 | 0.00% | 5,801 |
| 24-04-23 | 0.193 | 0.00% | 1,790 |
| 24-04-22 | 0.193 | +1.58% | 15,300 |
End-of-day quote Bucharest S.E., April 25, 2024
More quotes
Ropharma SA is a Romania-based company engaged in the pharmaceutical industry. The Company is active in the wholesale and retail of drugs. It also has a production facility of over-the-counter drugs and dietary supplements. The Company sells pharmaceutical products through its pharmacies located in the Romanian cities of Iasi, Vaslui, Suceava, Botosani, Bacau, Neamt, Vrancea, Mures, Harghita, Sibiu and Brasov. Through its distribution center, the Company provides drugs, food supplements, skin cosmetics and other products. It manufactures pharmaceutical products under the brand names Aesculap, Bioef and Eurofarmaco. As of December 31, 2011, Ropharma SA had six subsidiaries: Romanita-Farm Srl, Ropharma Production Srl, Aesculap Prod Srl, Ergo Farm Srl, Drops Farm Srl and Europharm Trading 7 SA.
Sector
Drug Retailers
| 1st Jan change | Capi. | |
|---|---|---|
| -2.50% | 21.39M | |
| -11.64% | 3.62B | |
| -0.09% | 3.36B | |
| -23.44% | 3.06B | |
| +7.46% | 2.59B | |
| -9.26% | 1.75B | |
| +9.30% | 1.35B | |
| -20.60% | 957M | |
| -38.42% | 704M | |
| -0.53% | 450M |
- Stock Market
- Equities
- RPH Stock
